Literature DB >> 8365822

Melatonin increases antigen presentation and amplifies specific and non specific signals for T-cell proliferation.

C Pioli1, M C Caroleo, G Doria.   

Abstract

Our preceding results have shown that melatonin administration to normal and immunodepressed mice increases significantly the antibody response. We also found that melatonin is able to restore the impaired T-helper cell activity in immunodepressed mice. The present study shows that melatonin enhances antigen presentation by splenic macrophages to T-cells. This effect is concomitant with an increase in the expression of MHC class II molecules and production of IL-1 and TNF-alpha. Considering the role of antigen presentation and cytokine production in the initiation of the immune response, the present findings provide evidence for relevant mechanisms that may account for the regulatory role of the pineal gland in immunoregulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8365822     DOI: 10.1016/0192-0561(93)90060-c

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  31 in total

1.  Chronic exposure to dim light at night suppresses immune responses in Siberian hamsters.

Authors:  Tracy A Bedrosian; Laura K Fonken; James C Walton; Randy J Nelson
Journal:  Biol Lett       Date:  2011-01-26       Impact factor: 3.703

Review 2.  The role of melatonin in immuno-enhancement: potential application in cancer.

Authors:  Sandra C Miller; S R Pandi-Perumal; Perumal S R Pandi; Ana I Esquifino; Daniel P Cardinali; Georges J M Maestroni
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

3.  Melatonin and doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines.

Authors:  Lu-Lu Fan; Guo-Ping Sun; Wei Wei; Zhang-Gui Wang; Lei Ge; Wei-Zheng Fu; Hua Wang
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

Review 4.  A review of the multiple actions of melatonin on the immune system.

Authors:  Antonio Carrillo-Vico; Juan M Guerrero; Patricia J Lardone; Russel J Reiter
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

5.  Combining immunotherapy and natural immune stimulants: mechanisms and clinical implications.

Authors:  Khara Lucius; Jacob Hill
Journal:  J Cancer Res Clin Oncol       Date:  2019-01-23       Impact factor: 4.553

6.  Effect of the preventive-therapeutic administration of melatonin on mammary tumour-bearing animals.

Authors:  M C Saez; C Barriga; J J Garcia; A B Rodríguez; E Ortega
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

Review 7.  Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization.

Authors:  B Farhood; N H Goradel; K Mortezaee; N Khanlarkhani; E Salehi; M S Nashtaei; H Mirtavoos-Mahyari; E Motevaseli; D Shabeeb; A E Musa; M Najafi
Journal:  Clin Transl Oncol       Date:  2018-08-22       Impact factor: 3.405

8.  Melatonin provides signal 3 to unprimed CD4(+) T cells but failed to stimulate LPS primed B cells.

Authors:  V Raghavendra; V Singh; A V Shaji; H Vohra; S K Kulkarni; J N Agrewala
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

Review 9.  Melatonin--a pleiotropic molecule involved in pathophysiological processes following organ transplantation.

Authors:  James E Fildes; Nizar Yonan; Brian G Keevil
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

10.  Plasma melatonin levels do not differ in SLE patients.

Authors:  P Wang; H-M Li; Y-F Zou; J-H Tao; H-F Pan
Journal:  Z Rheumatol       Date:  2018-02       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.